|Bid||2.1900 x 200|
|Ask||2.2400 x 2000|
|Day's Range||2.1804 - 2.2501|
|52 Week Range||0.0600 - 2.9500|
|PE Ratio (TTM)||-1.31|
|Earnings Date||Aug 8, 2017 - Aug 14, 2017|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||75.00|
CEL-SCI Corporation announces that it is extending the expiration date of its Series DD warrants by one month, from July 10, 2017 to August 10, 2017 .
NEW YORK, NY / ACCESSWIRE / July 3, 2017 / CEL-SCI was one of the biggest gainers on the NYSE last Friday as traders seemed very encouraged by how quickly the company plans to address changes that the ...
Categories: Yahoo FinanceGet free summary analysis CEL-SCI Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of CEL-SCI Corp. – Curis, Inc., BioCryst Pharmaceuticals, Inc., Amgen Inc., Xencor, Inc., CytRx Corporation, Johnson & Johnson, Vical Incorporated, Teva Pharmaceutical Industries Limited Sponsored ADR and Emergent BioSolutions Inc. ... Read more (Read more...)